This is a Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in Patients Suffering From Epilepsy in Early Access Program in Germany, France and UK
N/A
Cenobamate is a newly-FDA and EMA approved drug used to treat -focal-onset ...
Status
Completed
Location
Hôpital Pierre Wertheimer - Hopsices Civils de Lyon
Start Date
2023-01-27
Trial ID
NCT05747001
Study to Prevent Radiation Induced Damage to Bowel Using a Prebiotic Enhanced Diet.
PHASE3
The study will consist of pair of double-blind placebo-controlled trials of...
Effect of Dietary Carbohydrate Content and Inulin-Fructooligosaccharide Supplementation on Glycemic Control in Individuals With Type 1 Diabetes Mellitus
NA
Diabetes is a chronic metabolic disease in which nutrients such as carbohyd...